COVID-19 Vaccination and Clinical Outcomes at a Secondary Referral Hospital During the Delta Variant-dominant Period in West Sumatra, Indonesia

Didan Ariadapa Rahadi; Elfira Yusri; Syandrez Prima Putra; Rima Semiarty; Dian Pertiwi; Cimi Ilmiawati

doi:10.3961/jpmph.23.077

추천

검색

자료유형: 학술저널

저자정보: Didan Ariadapa Rahadi (Undergraduate Program of Medicine Faculty of Medicine Universitas Andalas Padang Indonesia) Elfira Yusri (Department of Clinical Pathology Undergraduate Program of Medicine Faculty of Medicine Universitas) Syandrez Prima Putra (Department of Microbiology Undergraduate Program of Medicine Faculty of Medicine Universitas Andal) Rima Semiarty (Department of Public Health Undergraduate Program of Medicine Faculty of Medicine Universitas Anda) Dian Pertiwi (Department of Clinical Pathology Undergraduate Program of Medicine Faculty of Medicine Universitas) Cimi Ilmiawati (Doctoral Program of Public Health Faculty of Medicine Universitas Andalas Padang Indonesia Departm)

저널정보: 대한예방의학회 예방의학회지 예방의학회지 제56권 제3호

발행연도: 2023.5

수록면: 221 - 230 (10page)

DOI: 10.3961/jpmph.23.077

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objectives: The second wave of coronavirus disease 2019 (COVID-19) cases in Indonesia, during which the Delta variant predominated, took place after a vaccination program had been initiated in the country. This study was conducted to assess the impact of COVID-19 vaccination on unfavorable clinical outcomes including hospitalization, severe COVID-19, intensive care unit (ICU) admission, and death using a real-world model.Methods: This single-center retrospective cohort study involved patients with COVID-19 aged ≥18 years who presented to the COVID-19 emergency room at a secondary referral teaching hospital between June 1, 2021 and August 31, 2021. We used a binary logistic regression model to assess the effect of COVID-19 vaccination on unfavorable clinical outcomes, with age, sex, and comorbidities as confounding variables.Results: A total of 716 patients were included, 32.1% of whom were vaccinated. The elderly participants (≥65 years) had the lowest vaccine coverage among age groups. Vaccination had an effectiveness of 50% (95% confidence interval [CI], 25 to 66) for preventing hospitalization, 97% (95% CI, 77 to 99) for preventing severe COVID-19, 95% (95% CI, 56 to 99) for preventing ICU admission, and 90% (95% CI, 22 to 99) for preventing death. Interestingly, patients with type 2 diabetes had a 2-fold to 4-fold elevated risk of unfavorable outcomes.Conclusions: Among adults, COVID-19 vaccination has a moderate preventive impact on hospitalization but a high preventive impact on severe COVID-19, ICU admission, and death. The authors suggest that relevant parties increase COVID-19 vaccination coverage, especially in the elderly population.

#COVID-19 #Vaccine #Vaccine outcome #Effectiveness #Indonesia

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!